COGT
Cogent Biosciences Inc
NASDAQ: COGT · HEALTHCARE · BIOTECHNOLOGY
$35.87
-1.29% today
Updated 2026-04-29
Market cap
$6.29B
P/E ratio
—
P/S ratio
861.15x
EPS (TTM)
$-2.16
Dividend yield
—
52W range
$5 – $44
Volume
2.1M
Cogent Biosciences Inc (COGT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $17.72M | $-18.64M | $-25.84M | $-32.49M | $-41.51M | $-35.85M | $-58.76M | $-118.64M | $-153.62M | $-207.79M | $-264.44M |
| Capital expenditures | $1.99M | $3.31M | $912000.00 | $549000.00 | $33000.00 | $320000.00 | $1.72M | $6.86M | $2.80M | $573000.00 | $1.55M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $248000.00 | $1.02M | $1.34M | $3.09M | $3.24M | $6.02M | $11.69M | $18.37M | $30.62M | $39.74M | $46.08M |
| Free cash flow | $15.72M | $-21.95M | $-26.75M | $-33.04M | $-41.55M | $-36.17M | $-60.48M | $-125.50M | $-156.42M | $-208.36M | $-266.00M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $204.77M | $-22.51M | $-79.80M | — | — | — |